Skip to main content

Nonprofit · EIN 91-2073087

PREECLAMPSIA FOUNDATION

Tax-exempt · MELBOURNE, FL 32934

Financials

$3M$2.6M2024$5.7M$2.6M2025
Revenue Expenses · by fiscal year end
Financials of PREECLAMPSIA FOUNDATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$5,663,361$2,627,991$3,035,370$6,017,039$335,224$5,681,815
December 31, 2024990 (amended)$3,048,206$2,627,476$420,730$3,135,264$605,672$2,529,592
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$4,359,011
of which government grants
$151,759
Membership dues
$7,250
Program service revenue
$646,317
Investment income
$112,915
Net gain from sales of assets
-$1,910
Net income from sales of inventory
$529,234
Other revenue
$545,118

Expenses

Grants and similar amounts paid
$226,774
Compensation of officers, directors and key employees
$110,000
Other salaries and wages
$1,057,947
Salaries, compensation and benefits (total)
$1,324,828
Professional fundraising fees
$0
Accounting fees
$97,338
Occupancy
$72,038
Travel
$53,828
Depreciation
$5,160
Program services (functional)
$2,016,088
Management and general (functional)
$411,494
Fundraising (functional)
$200,409

Balance sheet and other

Total assets, start of year
$3,135,264
Total assets, end of year
$6,017,039
Total liabilities, end of year
$335,224
Net assets, end of year
$5,681,815
Land, buildings and equipment
$5,088
Publicly traded securities
$3,947,984
Net assets without donor restrictions
$4,975,624
Net assets with donor restrictions
$706,191
Gross receipts
$6,342,739
Employees
23
Volunteers
1,000
Year formed
2000
State of legal domicile
WA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
ELENI TSIGASCEO
Officer
40$93,539$36,636
ROBYN D'ORIA MA RNC APNCHAIR
Trustee or director, Officer
2$0$0
FRAN AYALASOMAYAJULADIRECTOR
Trustee or director
2$0$0
RAKHI DIMINO MD MMM CPEIMMEDIATE PA
Trustee or director
2$0$0
RAPHAEL CHARBIT CFA CTPTREASURER
Trustee or director, Officer
2$0$0
JENNIFER DEYOUNGDIRECTOR
Trustee or director
2$0$0
MELISSA ANNE ANNIE CROSLOW JDVICE CHAIR
Trustee or director, Officer
2$0$0
JASMINE MAGODIRECTOR
Trustee or director
2$0$0
SUZANNE MARINELLODIRECTOR
Trustee or director
2$0$0
TODD MCLAUGHLINSECRETARY
Trustee or director, Officer
2$0$0
AKIESHA GILCREST SAINVILDIRECTOR
Trustee or director
2$0$0
990 for the year ended December 31, 2024: 12 people
NameTitleHours / weekCompensationOther / benefits
ELENI TSIGASCHIEF EXECUTIVE OFFICER
Officer
40$92,484$16,516
ROBYN DORIA MA RNC APNBOARD CHAIR
Trustee or director
2$0$0
RAKHI DIMINO MD MMM CPEIMMEDIATE PAST CHAIR
Trustee or director
2$0$0
MELISSA ANNE CROSLOW JDVICE CHAIR
Trustee or director, Officer
2$0$0
TODD MCLAUGHLINSECREATARY
Trustee or director, Officer
2$0$0
FRAN AYALASOMAYAJULADIRECTOR
Trustee or director
2$0$0
JENNIFER DEYOUNGDIRECTOR
Trustee or director
2$0$0
ALEN AMINIDIRECTOR
Trustee or director
2$0$0
RAPHAEL CHARBIT CFA CTPTREASURER
Trustee or director, Officer
2$0$0
JASMINE MAGODIRECTOR
Trustee or director
2$0$0
SUZANNE MARINELLODIRECTOR
Trustee or director
2$0$0
IRA BERNSTEIN MDEX-OFFICIO
Trustee or director
2$0$0

Address and contacts

Address (IRS master file)
3840 W EAU GALLIE BLVD STE 104, MELBOURNE, FL 32934-3286
In care of
% INTRINXEC MANAGEMENT INC
Principal officer (990 for 2025)
MELISSA ANNE ANNIE CROSLOW JD, 46804 BACKWATER DR, STERLING, VA 20169
Signed the 990
MELISSA ANNE ANNIE CROSLOW JD, BOARD CHAIR
Phone
(321) 421-6957
Return prepared by
MKA ADVISORY LLC

Mission

PREECLAMPSIA FOUNDATION: 2025 IMPACT STATEMENT SAVING LIVES AND IMPROVING OUTCOMES FOR MOTHERS AND BABIES IN 2025, THE PREECLAMPSIA FOUNDATION CONTINUED ITS UNWAVERING MISSION TO REDUCE MATERNAL AND INFANT ILLNESS AND DEATH DUE TO HYPERTENSIVE DISORDERS OF PREGNANCY. WITH A CLEAR FOCUS ON HEALTH EQUITY, PATIENT EMPOWERMENT, AND RESEARCH ADVANCEMENT, WE MADE TRANSFORMATIONAL PROGRESS ACROSS ALL FOUR STRATEGIC PILLARS: EDUCATE, ENGAGE, EQUIP, AND ELEVATE. EDUCATE: WE REACHED HUNDREDS OF THOUSANDS OF PATIENTS AND PROFESSIONALS WITH CRITICAL, LIFE-SAVING INFORMATION. OVER 275,800 PATIENT EDUCATION MATERIALS WERE DISTRIBUTED, ARMING FAMILIES WITH THE KNOWLEDGE THEY NEED TO ADVOCATE FOR THEMSELVES. SIMULTANEOUSLY, WE TRAINED MORE THAN 400 HEALTHCARE PROVIDERS AND COMMUNITY HEALTH WORKERS, ENSURING EARLY DETECTION AND PROPER MANAGEMENT OF PREECLAMPSIA IN DIVERSE CLINICAL SETTINGS. ENGAGE: WITH 80 PATIENT-FAMILY PARTNER QUALITY IMPROVEMENT ENGAGEMENTS, WE DEEPENED OUR COMMITMENT TO PATIENT-CEN

990 for the year ended December 31, 2025

Program accomplishments

  • COMMUNITY. INCREASE NATIONAL AWARENESS OF PREECLAMPSIA THROUGH EXTENSIVE MEDIA OUTREACH AND AWARENESS EVENTS, INCLUDING RAISING GLOBAL ATTENTION. MAINTAIN THE NUMBER ONE ONLINE PREECLAMPSIA WEBSITE IN THE UNITED STATES, PRODUCE PRINTED AND DIGITAL EDUCATIONAL MATERIALS, UTILIZE MULTIMEDIA AND A PEERTOPEER NETWORK TO PROVIDE EDUCATION AND SUPPORT TO THOSE AFFECTED BY PREECLAMPSIA. PROVIDE A CRISIS WARMLINE FOR PATIENT AND FAMILY SUPPORT, GUIDANCE AND EDUCATION. PROVIDE TRAINING AND CERTIFICATION TO PATIENTS AND FAMILY MEMBERS WHO WISH TO USE THEIR LIVED EXPERIENCE TO POSITIVELY IMPROVE HEALTHCARE PRACTICES, EDUCATION, AND AWARENESS INITIATIVES.
    Expenses $442,111 · revenue $466,706
  • HEALTHCARE PRACTICES. PROVIDE EDUCATION, RESOURCES AND TRAINING FOR HEALTHCARE PROFESSIONALS. ADVOCATE FOR INNOVATIVE PRACTICES WITH HEALTHCARE PROVIDERS, POLICYMAKERS, AND KEY OPINION LEADERS TO IMPROVE INPATIENT AND OUTPATIENT CARE, SUCH AS PROVIDING BLOOD PRESSURE MONITORS TO PATIENTS DURING PREGNANCY AND THE POSTPARTUM PERIOD AND TRAINING ALL HEALTHCARE PROVIDERS AND FIRST RESPONDERS TO APPROPRIATELY RECOGNIZE, DIAGNOSE AND TREAT POSTPARTUM PATIENTS. TRAIN HEALTHCARE PROVIDERS AND ADMINISTRATORS TO INTEGRATE PATIENT AND FAMILY PERSPECTIVES IN SAFETY AND QUALITY IMPROVEMENT INITIATIVES AT A LOCAL, STATE, AND NATIONAL LEVEL. MEASURE IMPACT OF INTEGRATING LIVED EXPERIENCE IN HEALTHCARE IMPROVEMENT INITIATIVES.
    Expenses $1,033,713 · revenue $1,556,797
  • RESEARCH. FUNDS AND ADVOCATES FOR RESEARCH INTO PATHOPHYSIOLOGY, DIAGNOSIS, PREVENTION, AND TREATMENT OF HYPERTENSIVE DISORDERS OF PREGNANCY. PROVIDES RESEARCH FUNDING THROUGH VISION GRANTS, PETER JOSEPH PAPPAS RESEARCH FUND, TRAVEL GRANTS TO SCIENTIFIC MEETINGS, AND OTHER RESEARCH PROJECTS. MAINTAINS ONLINE PATIENTLED PREECLAMPSIA RESEARCH REGISTRY AND PROVIDES STUDY PARTICIPANT RECRUITMENT SERVICES. CONDUCT AND PUBLISH PATIENT IMPACT AND CARE PRACTICE RESEARCH STUDIES. ENSURE PATIENTS FROM ALL DIFFERENT BACKGROUNDS HAVE ACCESS TO OPPORTUNITIES TO PARTICIPATE AND ACTIVELY ENGAGE IN PREECLAMPSIA RESEARCH. COLLABORATES WITH RESEARCH SCIENTISTS ON VARIOUS STUDIES AND CROSSLEARNING OPPORTUNITIES.
    Expenses $540,264 · grants $226,774 · revenue $2,866,193

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
91-2073087
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2001
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H80)
Assets (IRS master file)
$6,017,039
Income (IRS master file)
$6,342,739

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025–––IRS
990December 2024–––IRS
990December 2023$2,164,264$1,681,501$2,346,885IRS
990December 2022$1,582,437$1,461,032$1,631,500IRS
990December 2021$1,588,806$1,399,044$1,762,585IRS
990December 2020–––IRS
990December 2019–––IRS
990December 2018–––IRS

990-N: the IRS publishes only the latest e-Postcard per organization; earlier years appear here as 990.tax collects the monthly files. 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS.

Questions about PREECLAMPSIA FOUNDATION

What is the EIN of PREECLAMPSIA FOUNDATION?
The employer identification number (EIN) of PREECLAMPSIA FOUNDATION is 91-2073087.
Is PREECLAMPSIA FOUNDATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2001.
Are donations to PREECLAMPSIA FOUNDATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does PREECLAMPSIA FOUNDATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of PREECLAMPSIA FOUNDATION due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did PREECLAMPSIA FOUNDATION last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of PREECLAMPSIA FOUNDATION?
The 990 for the year ended December 31, 2025 names MELISSA ANNE ANNIE CROSLOW JD.
Who are the officers and directors of PREECLAMPSIA FOUNDATION?
The 990 for the year ended December 31, 2025 lists 11 people; 1 received compensation from the organization, the highest $93,539 (ELENI TSIGAS, CEO).
How much revenue does PREECLAMPSIA FOUNDATION have?
On its 990 for the year ended December 31, 2025 it reported revenue of $5,663,361, expenses of $2,627,991 and total assets of $6,017,039 at year end.

Other nonprofits in MELBOURNE

All nonprofits in MELBOURNE · Florida · Medical research